All News about Biocept, Inc. - Common Stock

Biocept Signs CNSide™ Licensing Agreement with Plus Therapeutics
September 08, 2023
From Biocept, Inc.
Via Business Wire


Biocept to Participate in the H.C. Wainwright Global Investment Conference
September 05, 2023
From Biocept, Inc.
Via Business Wire

From Biocept, Inc.
Via Business Wire


Biocept Reports Second Quarter 2023 Financial Results
August 14, 2023
From Biocept, Inc.
Via Business Wire




Via Benzinga


From Biocept, Inc.
Via Business Wire

From Biocept, Inc.
Via Business Wire






Via Benzinga




Via Benzinga




From Biocept, Inc.
Via Business Wire

Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.